Search clinical trials for: Human Rotavirus vaccine

Total 31052 results

GlaxoSmithKline

Recruiting

A Study on the Immune Response and Safety of Inactivated Poliovirus Vaccine (IPV) When Co-administered With Human Rotavirus (HRV) Porcine Circovirus (PCV)-Free Vaccine in Healthy Chinese Infants

Gastroenteritis

China
Sanofi Pasteur, a Sanofi Company

Completed

Study of a Pneumococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Toddlers and Infants

Pertussis Immunisation | Diphtheria Immunisation | Tetanus Immunisation | Pneumococcal Immunisation | Hepatitis B Immunisation | Haemophilus Influenzae Type b Immunisation | Polio Immunisation | Measles Immunisation | Rubella Immunisation | Varicella Immunisation | Mumps Immunisation

United States, Canada, Honduras, Puerto Rico
Sanofi Pasteur, a Sanofi Company

Completed

Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine in Infants and Toddlers When Administered Concomitantly With Routine Pediatric Vaccines in the United Kingdom (MET52)

Healthy Volunteers (Meningococcal Infection)

United Kingdom
Centre for Infectious Disease Research in Zambia
Institut National de la Santé Et de la Recherche Médicale, France; Imperial... and other collaborators

Active, not recruiting

Human Challenge With Live-attenuated Rotavirus to Assess Next-generation Rotavirus Vaccines in Africa

Diarrhea | Diarrhea Rotavirus

Zambia
Sanofi Pasteur, a Sanofi Company

Completed

Study of DTwP-HepB-Hib-IPV (SHAN6™) Vaccine Administered Concomitantly With Routine Pediatric Vaccines to Healthy Infants and Toddlers in Thailand

Pertussis Immunisation | Diphtheria Immunisation | Tetanus Immunisation | Pneumococcal Immunisation | Hepatitis B Immunisation | Polio Immunisation | Haemophilus Influenzae Type B Immunisation | Rotavirus Immunisation

Thailand
GlaxoSmithKline

Completed

Safety Study of 2 Formulations of GSK's Human Rotavirus (HRV) Vaccine (444563), in Healthy Infants Starting at Age 6-12 Weeks

Infections, Rotavirus

United States, Taiwan, Canada, Hong Kong, Turkey
National Institute of Allergy and Infectious Diseases...
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Completed

Safety and Immune Response of a Rotavirus Vaccine in HIV-infected and Uninfected Children Born to HIV-infected Mothers

HIV Infection | Rotavirus Infection

Botswana, Zimbabwe, Zambia, Tanzania
GlaxoSmithKline

Completed

To Evaluate Safety & Reactogenicity of GSK Bio's Human Rotavirus (HRV) Vaccine in Filipino Infants at Least 6 Weeks of Age at First Vaccination

Infections, Rotavirus | Rotavirus Vaccines

Philippines
GlaxoSmithKline

Completed

This Study Will Evaluate the Immunogenicity, Reactogenicity and Safety of the Routine Infant Vaccines Pediarix®, Hiberix® and Prevenar 13® When Co-administered With GlaxoSmithKline (GSK) Biologicals' Liquid Human Rotavirus Vaccine (HRV) as Compared to GSK's Licensed Lyophilized Vaccine

Rotavirus Infection | Rotavirus Vaccines

United States
GlaxoSmithKline

Completed

Immunogenicity, Reactogenicity and Safety Study of Two Different Formulations of GSK Biologicals' Human Rotavirus Vaccine, Rotarix, in Healthy Infants

Rotavirus

India
GlaxoSmithKline

Completed

Evaluation of Immunogenicity and Safety of Two Formulations of GSK Biologicals' Human Rotavirus (HRV) Vaccine (444563), in Healthy Infants Starting at Age 6-12 Weeks

Infections, Rotavirus | Rotavirus Vaccines

United States, Finland, Germany, Taiwan, Spain, Costa Rica, Korea, Republic of, Japan
GlaxoSmithKline

Completed

Evaluation of Reactogenicity and Safety of GSK Biologicals' Rotarix (Human Rotavirus Vaccine) in Infants

Infections, Rotavirus

Korea, Republic of
GlaxoSmithKline

Completed

A Study to Evaluate Immune Response and Safety of Two Doses of GSK Biologicals' HRV Liquid Vaccine in Healthy Infants.

Infections, Rotavirus | Rotavirus Vaccines

Philippines
GlaxoSmithKline

Completed

Evaluate Protective Efficacy of Diff Strengths of Human Rotavirus Vaccine After Admn of 2 Doses to Infants Aged 2 Months

Infections, Rotavirus
GlaxoSmithKline

Completed

Evaluation of Immunogenicity and Safety of the Diphtheria, Tetanus, Pertussis and Inactivated Poliovirus (DPT-IPV) Vaccine Squarekids Co-administered With GSK Biologicals' Human Rotavirus (HRV) Vaccine Rotarix (GSK444563) in Healthy Infants

Rotavirus

Japan
Centre for Infectious Disease Research in Zambia
Imperial College London; Christian Medical College, Vellore, India

Completed

Development of a Live Attenuated Rotavirus Vaccine as a Human Infection Challenge Model

Diarrhoeal Disease

Zambia
Serum Institute of India Pvt. Ltd.
PATH

Completed

Phase III Study on Rotavirus Vaccine to Evaluate Lot-to-lot Consistency and Interference With Routine UIP Immunization

Rotavirus Gastroenteritis

India
Serum Institute of India Pvt. Ltd.
PATH

Completed

A Clinical Trial to Study the Effect and Safety of Rotavirus Vaccine Against Severe Rotavirus Gastroenteritis in Healthy Indian Infants

Rotavirus Gastroenteritis

India
GlaxoSmithKline

Completed

Evaluation of Reactogenicity and Safety of GSK Biologicals' Rotarix™ (Human Rotavirus Vaccine) in Infants

Infections, Rotavirus

Sri Lanka
GlaxoSmithKline

Completed

Immunogenicity and Safety Study of Rotarix TM in Taiwanese Infants Who Received Hepatitis B Immunoglobulin After Birth.

Infections, Rotavirus

Taiwan
GlaxoSmithKline

Completed

Primary and Booster Vaccination Study With a Pneumococcal Vaccine in HIV Infected, HIV Exposed Uninfected and HIV Uninfected Children 6 to 10 Weeks of Age.

Infections, Streptococcal

South Africa
GlaxoSmithKline

Completed

Study to Assess the Efficacy, Immunogenicity and Safety of Liquid Human Rotavirus Vaccine, in Healthy Chinese Infants

Infections, Rotavirus

China
GlaxoSmithKline

Completed

To Assess Safety, Reactogenicity & Immunogenicity of 2 Doses of GSK's Oral Human Rotavirus Vaccine in Pre-Term Infants

Infections, Rotavirus

Spain, Poland, France, Portugal
GlaxoSmithKline

Completed

Immune Response Post Pry Vaccination of 2 Formulations of DTPw-HBV Vaccine Given With Rotavirus Vaccine to Infants

Hepatitis B

Russian Federation
GlaxoSmithKline

Completed

Reactogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Rotarix™ (Human Rotavirus Vaccine) in Indian Infants

Infections, Rotavirus

India
Sanofi Pasteur, a Sanofi Company

Completed

Concomitant Administration of a New Hexavalent Vaccine With a Meningococcal Serogroup C Conjugate Vaccine in Healthy Infants During Primary Series Immunisation Followed by Booster Vaccination

Virus Diseases | Bacterial Infections | Neisseria Meningitidis

Finland
GlaxoSmithKline

Completed

Assess the Immunogenicity & Safety of 2 Doses of Oral Live Attenuated Human Rota(HRV)Vaccine in Healthy Infants in India

Infections, Rotavirus

India
GlaxoSmithKline

Completed

Effectiveness of Human Rotavirus Vaccine, Rotarix™ Against Rotavirus Severe Gastroenteritis (RV SGE) in Infants

Rotavirus Severe Gastroenteritis

Singapore
GlaxoSmithKline

Completed

Study to Evaluate the Safety of Rotarix™ in Chinese Children

Infections, Rotavirus

China
GlaxoSmithKline

Completed

Study to Assess the Safety of GSK Biologicals' Liquid Human Rotavirus Vaccine in Healthy Infants

Infections, Rotavirus

China
GlaxoSmithKline

Completed

Study to Evaluate the Reactogenicity and Safety of Rotarix™ in Chinese Adults

Infections, Rotavirus

China
GlaxoSmithKline

Completed

Serological Response to Porcine Circovirus Type 1 (PCV-1) and PCV-1 DNA in Stools of Infants Following Administration of Rotarix™

Rotavirus Infection | Evidence of PCV-1 Replication and/or Immune Response to the PCV-1 in HRV Vaccinated Infants
GlaxoSmithKline

Completed

To Test 2 Doses of GSK Biologicals' Oral Live Attenuated Human Rotavirus (HRV) Vaccine in Healthy Infants in Co-administration With Specific Childhood Vaccines

Infections, Rotavirus

Finland, Germany, Spain, Italy, France, Czech Republic
Academisch Medisch Centrum - Universiteit van Amsterdam...
University of Padova; Centers for Disease Control and Prevention; Aga Khan University and other collaborators

Completed

The Influence of the Microbiome on Rotavirus Vaccine Immunogenic Response in Infants in Karachi, Pakistan

Rotavirus

Pakistan
GlaxoSmithKline

Completed

Assess the Immunogenicity of the Human Rotavirus (HRV) Vaccine After Reconstitution Without Buffering Agent; & Evaluate the Immunogenicity, Reactogenicity & Safety of the Vaccine After Storage for 7 d at 37°C Following 2 Doses in Healthy Infants

Rotavirus Gastroenteritis

Thailand
GlaxoSmithKline

Completed

Year 3 Extension for Efficacy Follow-up in Subjects Vaccinated in Studies Rota-028, 029 or 030 (NCT00197210)

Infections, Rotavirus

Singapore
GlaxoSmithKline

Completed

A Study to Test 2 Doses of GSK Biologicals' Oral Live Attenuated Human Rotavirus (HRV) Vaccine in Healthy Infants

Infections, Rotavirus

Singapore
GlaxoSmithKline

Completed

Study of 2 Doses of HRV Vaccine Given Concomitantly or Separately With Routine Vaccinations in Healthy Infants in USA

Infections, Rotavirus

United States
GlaxoSmithKline

Completed

A Study in Infants to Test Two Preparations (Freeze-dried or Liquid) of the Rotavirus Vaccine (HRV Vaccine).

Infections, Rotavirus

Finland
GlaxoSmithKline

Completed

Study of 2 Doses of HRV Vaccine Given Concomitantly With Routine EPI Vaccinations Including OPV in Healthy Infants

Infections, Rotavirus

Argentina, Brazil, Dominican Republic, Panama, Colombia, Honduras
GlaxoSmithKline

Completed

To Evaluate Immunogenicity, Reactogenicity & Safety of 2 Doses of GSK Bio HRV Liquid Vaccine Given to Infants (Vietnam)

Infections, Rotavirus

Vietnam
GlaxoSmithKline

Completed

Study of 2 Doses of Oral Live Attenuated Human Rotavirus (HRV) Vaccine for the Prophylaxis of Rotavirus Gastroenteritis

Infections, Rotavirus

Korea, Republic of
GlaxoSmithKline

Completed

Study of Immunogenicity & Safety of 2 Different Formulations of Human Rotavirus (HRV) Vaccine for the Prophylaxis of Rotavirus Gastroenteritis

Infections, Rotavirus

Finland
GlaxoSmithKline

Completed

Assess Efficacy, Immune Response & Safety of 2 Doses of Oral Live Attenuated HRV Vaccine at Different Viral Concentrations in Healthy Infants

Hepatitis B
GlaxoSmithKline

Completed

Assess Efficacy, Immune Response & Safety of 2 Doses of Oral Live Attenuated HRV Vaccine in Healthy Infants

Infections, Rotavirus
GlaxoSmithKline

Completed

Study of Two Doses of GSK Biologicals' Live Attenuated HRV Vaccine (Two Different Formulations) in Healthy Infants.

Infections, Rotavirus
GlaxoSmithKline

Completed

To Evaluate 2 Doses of GSK Biologicals' Oral Live Attenuated Human HRV Vaccine Co-administered With Either OPV or IPV

Rotavirus Infections

South Africa
PATH
Centers for Disease Control and Prevention; Noguchi Memorial Institute for... and other collaborators

Completed

Evaluation of the Human Rotavirus Vaccine at Varying Schedules and Doses in Rural Ghana

Rotavirus Gastroenteritis

Ghana
GlaxoSmithKline

Completed

Serologic Response to Porcine Circovirus Type 1 (PCV-1) in Infants Following Administration of Rotarix™

Infections, Rotavirus
International Centre for Diarrhoeal Disease Research...
PATH

Completed

Introduction of an Oral Live Human Rotavirus (Rotarix) Vaccine in Matlab

Rotavirus Gastroenteritis

Bangladesh

3

Subscribe